Sign in
4

Changes in Ownership

Aldeyra Therapeutics, Inc. Filed Acc 0000899243-18-015767

Options or other derivatives

  • Director acquired 17,331 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Phillips Gary M. Director 2018-06-07 Grant or award · Employee Stock Option (Right to Buy) +15,526 15,526 D
Phillips Gary M. Director 2018-06-07 Grant or award · Employee Stock Option (Right to Buy) +1,805 1,805 D
Loading xslF345X03/doc4.xml…